Correlogic Ovarian Cancer Test Market Advance Supported By NCI/FDA, Labs
This article was originally published in The Gray Sheet
Executive Summary
Quest and LabCorp are vowing to offer a "homebrew" ovarian cancer test based on Correlogic's computer artificial intelligence technology by year-end
You may also be interested in...
Ciphergen Diagnostics Strategy Includes Fall Ovarian Cancer Test Debut
Ciphergen's nascent diagnostics division will be built with research contributed by customers of its ProteinChip research tools unit
Ciphergen Diagnostics Strategy Includes Fall Ovarian Cancer Test Debut
Ciphergen's nascent diagnostics division will be built with research contributed by customers of its ProteinChip research tools unit
FDA Ethics Under Spotlight Of House Oversight Subcommittee Investigation
The House Energy & Commerce/Oversight & Investigations Subcommittee is shifting its ongoing ethics investigation toward FDA, Rep. Joe Barton (R-Texas) said May 18 at an NIH ethics hearing